Drew Burdon
Drew Burdon is a Partner in the EQT Life Sciences team, focusing on the Health Economics strategy. Drew joined LSP in 2019, and the firm was renamed EQT Life Sciences in 2022 when it joined forces with EQT. Prior to joining LSP, Drew spent 13 years at Smith & Nephew in London across R&D and commercial strategy roles, most recently as Director of Corporate Development. Before that, he was a Senior Scientific Officer at Cancer Research UK in Leeds. Drew holds a BSc (Hons) in Medical Biochemistry and a PhD in Cell and Molecular Biology, both from the University of Leicester, and an MBA from the Open University (UK).
- Office
- London
- Division
- Private Capital EU & NA
- Team
- EQT Life Sciences
More people within Private Capital EU & NA
Adam Scheid
Partner
Albert Gustafsson
Partner
Ali Farahani
Partner, PE Office Head Stockholm & Helsinki
Andreas Aschenbrenner
Partner, Co Head of EQT Future, Private Capital
Anne Portwich
Partner
Anthony Santospirito
Partner, Healthcare Team Lead
Arvindh Kumar
Partner, Co-Head of Technology, Private Equity
Bert Janssens
Co-Head of Private Capital
Carlos Santana
Partner, Head of Spain, Private Capital
Carolina Brochado
Head of EQT Ventures & Head of Growth US
Chris Litchford
Partner
Christian Shin Andersen
Partner, Head of Denmark & Norway, Private Capital
